SEC Form SC 13G/A filed by P3 Health Partners Inc. (Amendment)
$PIII
Medical/Nursing Services
Health Care
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/28/2025 | $20.00 | Buy | Lake Street |
| 4/1/2024 | Buy → Neutral | BTIG Research | |
| 9/1/2023 | $5.00 | Buy | BTIG Research |
| 6/30/2023 | Market Perform | TD Cowen | |
| 1/4/2022 | Outperform | William Blair |
Lake Street resumed coverage of P3 Health Partners with a rating of Buy and set a new price target of $20.00
BTIG Research downgraded P3 Health Partners from Buy to Neutral
BTIG Research initiated coverage of P3 Health Partners with a rating of Buy and set a new price target of $5.00
GREENWOOD VILLAGE, Colo., Aug. 25, 2025 /PRNewswire/ -- Catalyst Solutions is thrilled to announce the successful go-live of the Professional Health Partners Services (P3) Implementation, which officially launched in May 2025. P3 Health Partners is a population health management organization that supports providers with administrative services and care coordination for Medicare members. This milestone marks a significant achievement in Catalyst's work to help P3 deliver high-quality, efficient service to members across a multi-state footprint. P3 operates in Arizona, Oregon, N
Core Business Demonstrates Strength with Flat Medical Cost Trends Despite Industry Inflation $120-$170 Million in Additional EBITDA Opportunities Identified for 2026 Adjusted Full Year Guidance Reflects Prior Period Headwinds Management to Host Conference Call and Webcast August 14, 2025 at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2025. "Our core business continues to strengthen as we execute on our $130 million EBITDA improvement plan," said Aric Coffman, CEO of P3. "While we faced prior period head
P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for second quarter 2025 and file its Quarterly Report on Form 10-Q on Thursday, August 14, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/4:30pm ET the same day. Title & Webcast P3 Health Second Quarter Earnings Conference Call Date & Time August 14, 2025, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 (US) International 1-412-317-0692 Ask to be joined into th
4 - P3 Health Partners Inc. (0001832511) (Issuer)
4 - P3 Health Partners Inc. (0001832511) (Issuer)
4 - P3 Health Partners Inc. (0001832511) (Issuer)
4 - P3 Health Partners Inc. (0001832511) (Issuer)
4 - P3 Health Partners Inc. (0001832511) (Issuer)
4 - P3 Health Partners Inc. (0001832511) (Issuer)
8-K - P3 Health Partners Inc. (0001832511) (Filer)
10-Q - P3 Health Partners Inc. (0001832511) (Filer)
8-K - P3 Health Partners Inc. (0001832511) (Filer)
P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, announced today that Leif Pedersen, an experienced finance, operational and value-based care executive, will join the company as chief financial officer (CFO) effective October 1, 2024. Pedersen succeeds Atul Kavthekar, who will continue as CFO until September 30, 2024, after which he will serve as a Strategic Advisor to the company. Pedersen was most recently Vice President of Finance & CFO Shared Services for Optum Health, a division of UnitedHealth Group. Prior to Optum Health, Pedersen served as Vice President of Finance & CFO IT at DaVita Medical Group. He brings m
P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), today named Dr. Aric Coffman as P3's Chief Executive Officer, effective as of May 8, 2024, succeeding Dr. Sherif Abdou, P3's Co-Founder. Dr. Abdou will continue to serve as a Strategic Advisor to P3, and a member of the Company's Board of Directors working closely with Dr. Coffman to ensure a smooth transition. Dr. Coffman is an exceptional physician leader with a proven track record of success in the value-based care sector, most recently as the CEO of Honest Medical Group, a Rubicon Founders portfolio company. He brings over two decades of experience in leading provider organizations in delivering high quality, highly effici
Core Business Demonstrates Strength with Flat Medical Cost Trends Despite Industry Inflation $120-$170 Million in Additional EBITDA Opportunities Identified for 2026 Adjusted Full Year Guidance Reflects Prior Period Headwinds Management to Host Conference Call and Webcast August 14, 2025 at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2025. "Our core business continues to strengthen as we execute on our $130 million EBITDA improvement plan," said Aric Coffman, CEO of P3. "While we faced prior period head
P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for second quarter 2025 and file its Quarterly Report on Form 10-Q on Thursday, August 14, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/4:30pm ET the same day. Title & Webcast P3 Health Second Quarter Earnings Conference Call Date & Time August 14, 2025, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 (US) International 1-412-317-0692 Ask to be joined into th
Affirming 2025 guidance Management to Host Conference Call and Webcast May 15, 2025 at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its financial results for the first quarter ended March 31, 2025, and affirmed its 2025 guidance. "Our physician-led care enablement model continues to differentiate P3, delivering meaningful improvements in quality measures and cost management through deeper provider partnerships," said Aric Coffman, CEO of P3. "Our turnaround plan is ahead of schedule, with three of four markets already achieving breakeven or better in Q1. Beyond our ori
SC 13G - P3 Health Partners Inc. (0001832511) (Subject)
SC 13D/A - P3 Health Partners Inc. (0001832511) (Subject)
SC 13D/A - P3 Health Partners Inc. (0001832511) (Subject)